Showing results (2231-2240 of 3,023) with videos related to

Sort By:
Pageof 303
Anticancer Research|January 25, 2008
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II studyP Kosmidis, G Fountzilas, S Baka, et al.
British Journal of Haematology|November 19, 2014
Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasoneGareth Morgan, Antonio Palumbo, Sujith Dhanasiri, et al.
Anticancer Research|August 6, 2005
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II studyDimosthenis V Skarlos, Haralabos P Kalofonos, George Fountzilas, et al.
Current Oncology (Toronto, Ont.)|August 27, 2025
Multi-Level Oncological Management of a Rare, Combined Mediastinal Tumor: A Case ReportVasileios Theocharidis, Thomas Rallis, Apostolos Gogakos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2012
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomesGiovanni Palladini, Angela Dispenzieri, Morie A Gertz, et al.
Blood|November 23, 2016
BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 yearsMaria Gavriatopoulou, Ramón García-Sanz, Efstathios Kastritis, et al.
The Lancet. Haematology|July 1, 2018
Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart reviewChristian Buske, Shalal Sadullah, Efstathios Kastritis, et al.
Urology|January 25, 2011
Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancerIoannis Mountzios, Evangelos Bournakis, Eleni Efstathiou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II studyV Georgoulias, N Androulakis, A M Dimopoulos, et al.
Acta Neuropathologica Communications|April 23, 2016
TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapyHelga D Munch-Petersen, Fazila Asmar, Konstantinos Dimopoulos, et al.
Pageof 303